We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF

6 hedge funds and large institutions have $1.99M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

96% more call options, than puts

Call options by funds: $4.24M | Put options by funds: $2.17M

0.01% less ownership

Funds ownership: 0.01%0% (-0.01%)

25% less funds holding

Funds holding: 86 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

66% less capital invested

Capital invested by funds: $5.78M → $1.99M (-$3.8M)

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
4
Calls
$4.24M
Puts
$2.17M
Net Calls
+$2.08M
Net Calls Change
+$2.08M

LABD Hedge Fund Activity: Q4 2015 in Review

6 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2015, worth a combined $1.99M — down 66% from $5.78M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LABD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Jane Street, adding an estimated $841K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.38M sold.

  • 6 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2015, down from 8 in Q3 2015.
  • Funds reported $1.99M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2015, down 66% quarter-over-quarter.
  • 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2015 and 4 closed out, a net change of -2 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2015 was Jane Street, an estimated $841K added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2015 was Susquehanna International Group, an estimated $1.38M sold.

Based on aggregated 13F filings for Q4 2015.